Global Reach Axilum Robotics has customers in 21 countries, presenting a solid foundation for international expansion and channel partnerships. Target global hospitals, research institutes, and distributors to scale adoption of TMS and ultrasound robotic solutions.

Regulatory Leader As the first company to obtain CE marking and FDA 510(k) for a collaborative robotic arm in TMS workflows, Axilum demonstrates strong regulatory credibility. Position for partners seeking compliant, clinically validated robotics for neurostimulation and imaging applications.

Product Expansion Sequential platform evolution from TMS-Robot to TMS-Cobot and now TUS-Cobot indicates a roadmap toward multimodal neurostimulation and ultrasound guidance. Opportunity to upsell integrated robotic solutions to existing customers and cross-sell to research centers.

Quality Backbone ISO 13485 certified since 2013 underpins reliability and quality management. Leverage quality credentials in discussions with procurement teams prioritizing standards-driven medical device partnerships and long lifecycle service agreements.

Research Driven Active participation in brain stimulation conferences and a focus on research partnerships suggest openings for collaborative pilots, consortiums, and early-access programs. Approach academic centers with co-development and grant-aligned opportunities.